Annual Net Income
-$9.72 M
+$87.61 M+90.01%
December 1, 2024
Summary
- As of March 15, 2025, FULC annual net profit is -$9.72 million, with the most recent change of +$87.61 million (+90.01%) on December 1, 2024.
- During the last 3 years, FULC annual net income has risen by +$71.12 million (+87.97%).
- FULC annual net income is now at all-time high.
Performance
FULC Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$16.57 M
+$5.13 M+23.64%
December 31, 2024
Summary
- As of March 15, 2025, FULC quarterly net profit is -$16.57 million, with the most recent change of +$5.13 million (+23.64%) on December 31, 2024.
- Over the past year, FULC quarterly net income has increased by +$8.19 million (+33.07%).
- FULC quarterly net income is now -129.90% below its all-time high of $55.41 million, reached on June 30, 2024.
Performance
FULC Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$9.72 M
+$8.19 M+45.71%
December 31, 2024
Summary
- As of March 15, 2025, FULC TTM net profit is -$9.72 million, with the most recent change of +$8.19 million (+45.71%) on December 31, 2024.
- Over the past year, FULC TTM net income has increased by +$87.61 million (+90.01%).
- FULC TTM net income is now -40.13% below its all-time high of -$6.94 million, reached on March 31, 2018.
Performance
FULC TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
FULC Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +90.0% | +33.1% | +90.0% |
| 3 y3 years | +88.0% | +33.1% | +90.0% |
| 5 y5 years | +88.2% | +33.1% | +90.0% |
FULC Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +91.2% | -129.9% | +51.4% | at high | +91.2% |
| 5 y | 5-year | at high | +91.2% | -129.9% | +51.4% | at high | +91.2% |
| alltime | all time | at high | +91.2% | -129.9% | +55.0% | -40.1% | +91.2% |
Fulcrum Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$16.57 M(-23.6%) | -$9.72 M(-45.7%) |
| Dec 2024 | -$9.72 M(-90.0%) | - | - |
| Sep 2024 | - | -$21.70 M(-139.2%) | -$17.91 M(-11.5%) |
| Jun 2024 | - | $55.41 M(-306.2%) | -$20.23 M(-79.6%) |
| Mar 2024 | - | -$26.87 M(+8.5%) | -$99.43 M(+2.1%) |
| Dec 2023 | -$97.33 M(-11.4%) | -$24.76 M(+3.1%) | -$97.33 M(-1.4%) |
| Sep 2023 | - | -$24.02 M(+1.0%) | -$98.71 M(+0.3%) |
| Jun 2023 | - | -$23.78 M(-4.0%) | -$98.44 M(-9.5%) |
| Mar 2023 | - | -$24.78 M(-5.2%) | -$108.72 M(-1.0%) |
| Dec 2022 | -$109.87 M(+35.9%) | -$26.14 M(+10.1%) | -$109.87 M(+2.5%) |
| Sep 2022 | - | -$23.74 M(-30.3%) | -$107.22 M(+2.9%) |
| Jun 2022 | - | -$34.07 M(+31.4%) | -$104.20 M(+16.1%) |
| Mar 2022 | - | -$25.93 M(+10.4%) | -$89.78 M(+11.0%) |
| Dec 2021 | -$80.85 M | -$23.48 M(+13.4%) | -$80.85 M(+7.7%) |
| Sep 2021 | - | -$20.72 M(+5.4%) | -$75.08 M(+2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$19.65 M(+15.6%) | -$73.33 M(+5.7%) |
| Mar 2021 | - | -$17.00 M(-4.1%) | -$69.37 M(-2.1%) |
| Dec 2020 | -$70.82 M(-14.3%) | -$17.72 M(-6.5%) | -$70.82 M(+2.3%) |
| Sep 2020 | - | -$18.96 M(+20.9%) | -$69.22 M(+3.6%) |
| Jun 2020 | - | -$15.69 M(-15.0%) | -$66.80 M(+3.9%) |
| Mar 2020 | - | -$18.45 M(+14.4%) | -$64.29 M(-22.2%) |
| Dec 2019 | -$82.68 M(+153.7%) | -$16.12 M(-2.5%) | -$82.68 M(+9.6%) |
| Sep 2019 | - | -$16.54 M(+25.6%) | -$75.41 M(+11.2%) |
| Jun 2019 | - | -$13.17 M(-64.3%) | -$67.81 M(+8.5%) |
| Mar 2019 | - | -$36.84 M(+315.9%) | -$62.49 M(+91.8%) |
| Dec 2018 | -$32.59 M(+41.9%) | -$8.86 M(-0.9%) | -$32.59 M(+37.3%) |
| Sep 2018 | - | -$8.94 M(+14.0%) | -$23.73 M(+60.5%) |
| Jun 2018 | - | -$7.85 M(+13.1%) | -$14.79 M(+113.1%) |
| Mar 2018 | - | -$6.94 M | -$6.94 M |
| Dec 2017 | -$22.96 M | - | - |
FAQ
- What is Fulcrum Therapeutics annual net profit?
- What is the all time high annual net income for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics annual net income year-on-year change?
- What is Fulcrum Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics quarterly net income year-on-year change?
- What is Fulcrum Therapeutics TTM net profit?
- What is the all time high TTM net income for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics TTM net income year-on-year change?
What is Fulcrum Therapeutics annual net profit?
The current annual net income of FULC is -$9.72 M
What is the all time high annual net income for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high annual net profit is -$9.72 M
What is Fulcrum Therapeutics annual net income year-on-year change?
Over the past year, FULC annual net profit has changed by +$87.61 M (+90.01%)
What is Fulcrum Therapeutics quarterly net profit?
The current quarterly net income of FULC is -$16.57 M
What is the all time high quarterly net income for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high quarterly net profit is $55.41 M
What is Fulcrum Therapeutics quarterly net income year-on-year change?
Over the past year, FULC quarterly net profit has changed by +$8.19 M (+33.07%)
What is Fulcrum Therapeutics TTM net profit?
The current TTM net income of FULC is -$9.72 M
What is the all time high TTM net income for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high TTM net profit is -$6.94 M
What is Fulcrum Therapeutics TTM net income year-on-year change?
Over the past year, FULC TTM net profit has changed by +$87.61 M (+90.01%)